News | May 25, 2023
Mandaviya addresses 76th World Health Assembly
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
The need is to focus on an enabling framework to bridge the digital divide across countries specifically amongst low-and-middle-income countries
Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
India has a pivotal role in eliminating TB
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
Subscribe To Our Newsletter & Stay Updated
